1. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.
- Author
-
Zhu, Kai, Pan, Qi, Zhang, Xin, Kong, Ling-Qun, Fan, Jia, Dai, Zhi, Wang, Lu, Yang, Xin-Rong, Hu, Jie, Wan, Jin-Liang, Zhao, Yi-Ming, Tao, Zhong-Hua, Chai, Zong-Tao, Zeng, Hai-Ying, Tang, Zhao-You, Sun, Hui-Chuan, and Zhou, Jian
- Subjects
MICRORNA ,VASCULAR endothelial growth factors ,ENDOTHELIAL cells ,LIVER cancer ,GENE expression ,GENETIC regulation ,PLATELET-derived growth factor receptors - Abstract
Endothelial cells (ECs) are critical for angiogenesis, and microRNAs play important roles in this process. We investigated the regulatory role of microRNAs in ECs of hepatocellular carcinoma (HCC) by examining the microRNA expression profile of human umbilical vein endothelial cells (HUVECs) in the absence or presence of human HCC cells, and identified miR-146a as the most highly upregulated microRNA. Furthermore, we revealed that miR-146a promoted the expression of platelet-derived growth factor receptor α (PDGFRA) in HUVECs, and this process was mediated by BRCA1. Overexpression of PDGFRA in the ECs of HCC tissues was associated with microvascular invasion and predicted a poorer prognosis. These results suggest that miR-146a plays a key role in regulating the angiogenic activity of ECs in HCC through miR-146a–BRCA1–PDGFRA pathway. MiR-146a and PDGFRA may emerge as potential anti-angiogenic targets on ECs for HCC therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF